Lupus nephritis results from an acute inflammatory and immunological response to renal immune complex deposition. The acute response is characterized by activation of circulating leukocytes and renal parenchymal cells, triggering the production of pro-inflammatory cytokines and growth factors. In all too many cases, this response is followed by a chronic response, which is characterized by excessive deposition of collagen and other extracellular matrix macromolecules and the development of end-stage renal disease. Mechanisms underlying this chronic response in progressive renal disease are not adequately defined. In this overview, potential roles of reactive oxygen species (ROS) generation and transforming growth factor-β (TGF-β) production in the pathogenesis of lupus nephritis are considered. ROS and TGF-β may be key elements of a pathway leading to persistent and excessive matrix deposition in progressive lupus nephritis. Further studies to define the role of this pathway in lupus nephritis may lead to the development of additional, more specific therapeutic targets to prevent progression of renal disease.
Austin HA III et al. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome . Kidney Int1984; 25: 689–695 .
2.
Studer RK , Craven PA , DeRubertis FR . Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells . Metabolism1997; 46 (8): 918–925 .
3.
Studer RK , Craven PA , DeRubertis FR . Low-density lipoprotein stimulation of mesangial cell fibronectin synthesis: role of protein kinase C and transforming growth factor-b . J Lab Clin Med1995; 125: 86–95 .
4.
Hahn BH . Antibodies to DNA . TN Engl J Med1998; 338 (19): 1359–1368 .
Burlingame RW , Boey ML , Starkebaum G , Rubin RL . The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus . J Clin Invest1994; 94 (1): 184–192 .
7.
Mohan C , Adams S , Stanki V , Datta SK . Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus . J Exp Med1993; 177: 1367–1381 .
8.
Madaio MP , Schlomchik MJ . Emerging concepts regarding B cells and autoantibodies in murine lupus nephritis. B cells have multiple roles; all autoantibodies are not equal . J Am Soc Nephrol1996; 7: 387–396 .
9.
van Bruggen MC et al. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis . Nephrol Dial Transplant1997; 12: 57–66 .
10.
Sabbaga J et al. Cross-reactivity distinguishes serum and nephritogenic anti-DNA antibodies in human lupus from their natural counterparts in normal serum . J Autoimmun1990; 3: 215–235 .
11.
Foster MH , Cizman B , Madaio MP . Nephritogenic autoantibodies in systemic lupus erthyematosus: immunochemical properties, mechanisms of immune deposition, and genetic origins . Lab Invest1993; 69: 494–507 .
12.
Couser WG . Mediation of immune glomerular injury . J Am Soc Nephrol1990; 1: 13–29 .
13.
Eddy AA , Michael AF . Immunopathogenic mechanisms of glomerular injury. In: Tisher CC , Brenner BM (eds.) Renal Pathology, vol 1. JB Lippincott: Philadelphia1994; pp 162–221.
14.
Hashimoto Y , Ziff M , Hurd ER . Increased endothelial cell adherence, aggregation, and superoxide generation by neutrophils incubated in systemic lupus erythematosus and Felty's syndrome sera . Arthritis Rheum1982; 25: 1409–1418 .
15.
Larsen CG et al. The neutrophil activating protein (NAP-1) is also chemotactic for T lymphocytes . Science1989; 243: 1464–1466 .
16.
Matsushima K , Oppenheim JJ . Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF . Cytokine1989; 1 (1): 213-213 .
17.
Lai KN , Leung JCK , Lai KB , Lai CKW . Effect of anti-DNA autoantibodies on the gene expression of interleukin 8, transforming growth factor-b, and nitric oxide synthase in cultured endothelial cells . Scand J Rheumatol1997; 26: 461–467 .
18.
Tsai CY et al. Polyclonal IgG anti-dsDNA antibodies exert cytotoxic effect on cultured rat mesangial cells by binding to cell membrane and augmenting apoptosis . Scand J Rheumatol1993; 22: 162–171 .
19.
Nath KA , Fischereder M , Hostetter TH . The role of oxidants in progressive renal injury . Kidney Int1994; 45: S111–S115 .
20.
Radeke HH et al. Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells . Kidney Int1990; 37: 767–775 .
21.
Sedor JR , Carey SW , Emancipator SN . Immune complexes bind to cultured rat glomerular mesangial cells to stimulate superoxide release . J Immunol1987; 138 (11): 3751–3757 .
22.
Baud L , Perez J , Ardaillou R . Dexamethasone and hydrogen peroxide production by mesangial cells during phagocytosis . Am J Physiol1986; 250: F596–F604 .
23.
Suryaprabha P et al. Reactive oxygen species, lipid peroxides and essential fatty acids in patients with rheumatoid arthritis and systemic lupus erythematosus . Prostaglandins Leukot Essent Fatty Acids1991; 43: 251–255 .
24.
Farber JL , Kyle ME , Coleman JB . Mechanisms of cell injury by activated oxygen species . Lab Invest1990; 62 (6): 670–679 .
25.
Cooke MS et al. Immunogenicity of DNA damaged by reactive oxygen species: implications for anti-DNA antibodies in lupus . Free Radic Biol Med1997; 22: 151–159 .
26.
Frenkel K , Karkoszka J , Kim E , Taioli E . Recognition of oxidized DNA bases by sera of patients with inflammatory diseases . Free Radic Biol Med1993; 14: 483–494 .
27.
Blount S , Griffiths HR , Lunec J . Reactive oxygen species induce antigenic changes in DNA . FEBS Lett1989; 245: 100–104 .
28.
Alam K , Ali A , Ali R . The effect of hydroxyl radical on the antigenicity of native DNA . FEBS Lett1993; 319: 66–70 .
29.
Lunec J et al. 8-Hydroxydeoxyguanosine: a marker of oxidative DNA damage in systemic lupus erythematosus . FEBS Lett1994; 348: 131–138 .
30.
Duque I et al. Calcium channel blockers inhibit hydrogen peroxideinduced proliferation of cultured rat mesangial cells . J Pharmacol Exp Ther1993; 267: 612–616 .
31.
Sundaresan M et al. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction . Science1995; 270: 296–299 .
32.
Satriano JA et al. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1 and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factoralpha and immunoglobin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADH)-dependent oxidase . J Clin Invest1993; 92: 1564–1571 .
33.
Natarajan V . Oxidants and signal transduction in vascular endothelium . J Lab Clin Med1995; 125: 26–37 .
34.
Barchowsky A et al. Oxidant-sensitive and phosphorylation-dependent activation of NF-kB and AP-1 in endothelial cells . Am J Physiol1995; 269: L829–L836 .
35.
Ammendola R , Mesuraca M , Russo T , Cimino F . The DNA-binding efficiency of Sp1 is affected by redox changes . Eur J Biochem1994; 225: 483–489 .
36.
Kim SJ et al. Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex . Mol Cell Biol1990; 10: 1492–1497 .
37.
Inagaki Y , Truter S , Ramirez F . Transforming growth factor-beta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site . J Biol Chem1994; 269: 14828–14834 .
38.
Jimenez SA et al. Functional analysis of human alpha 1(I) procollagen gene promoter. Differential activity in collagen-producing and nonproducing cells and response to transforming growth factor beta 1 . J Biol Chem1994; 269: 12684–12691 .
39.
Poli G , Parola M . Oxidative damage and fibrogenesis . Free Radic Biol Med1997; 22: 287–305 .
40.
Houglum K , Brenner DA , Chojkier M . D-Tocopherol inhibits collagen a1(I) gene expression in cultured human fibroblasts. Modulation of constitutive collagen gene expression by lipid peroxidations . J Clin Invest1991; 87: 2230–2235 .
41.
Ricardo SD , Ding G , Eufemio M , Diamond JR . Antioxidant expression in experimental huronephrosis: role of mechanical stretch and growth factors . Am J Physiol1997; 272: F789–F798 .
42.
Nath KA et al. Redox regulation renal DNA synthesis, TGF-b1 and collagen gene expression . Kidney Int1998; 53: 367–381 .
43.
Yoshioka K et al. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys . Lab Invest1993; 68: 154–163 .
44.
Yamamoto T et al. Expression of transforming growth factor-beta isoforms in human glomerular diseases . Kidney Int1996; 49 (2): 461–469 .
45.
Assoian RD , Sporn MB . Type b transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells . J Cell Biol1986; 102: 1219–1223 .
46.
Assoian RD et al. Expression and secretion of type b transforming growth factor by activated human macrophages . Proc Natl Acad Sci USA1987; 84: 6020–6024 .
47.
Kehrl JH et al. Production of transforming growth factor b by human T lymphocytes and its potential role in the regulation of T cell growth . J Exp Med1986; 163: 1037–1050 .
48.
MacKay K et al. Expression of transforming growth factor-beta-1 and beta-2 in rat glomeruli . Kidney Int1990; 38: 1095–1100 .
49.
Wahl SM . Transforming growth factor beta (TGF-b) in inflammation: a cause and a cure . J Clin Immunol1992; 12: 61–74 .
50.
Roberts AB et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro . Proc Natl Acad Sci USA1986; 83: 4167–4171 .
51.
Pierce GF et al. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms . J Cell Biol1989. 109: 429–440 .
52.
Pierce GF , Brown D , Mustoe TA . Quantitative analysis of inflammatory cell influx, procollagen type I synthesis, and collagen cross-linking in incisional wounds: influence of PDGF-BB and TGF-beta 1 therapy . J Lab Clin Med1991; 117: 373–382 .
53.
Wahl SM , McCartney-Francis N , Mergenhagen SE . Inflammatory and immunomodulatory roles of TGF-beta . Immunol Today1989; 10: 258–261 .
54.
Ahuja SS et al. Effect of transforming growth factor-b on early and late activation events in human T cells . J Immunol1993; 150: 3109–3118 .
55.
Kitamura M et al. Transfer of a mutated gene encoding active transforming growth factor-beta suppresses mitogenesis and IL-1 response in the glomerulus . Kidney Int1995; 48: 1747–1757 .
56.
Kulkarni AB et al. Transforming growth factor beta-1 null mutation in mice causes excessive inflammatory response and early death . Proc Natl Acad Sci USA1993; 90: 770–774 .
57.
Kulkarni AB , Karlsson S . Transforming growth factor beta-1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease . Am J Pathol1993; 143: 3–9 .
58.
Dang H et al. SLE-like autoantibodies and Sjogren's syndrome-like lumphoproliferation in TGF-beta knockout mice . J Immunol1995; 155: 3205–3212 .
59.
Border WA , Ruoslahti E . Transforming growth factor beta in disease: the dark side of tissue repair . J Clin Invest1992; 90: 1–7 .
60.
MacKay K et al. Transforming growth factor beta. Murine glomerular receptors and responses of isolated glomerular cells . J Clin Invest1989; 83: 1160–1167 .
61.
Border WA , Okuda S , Languino LR , Ruoslahti E . Transforming growth factor-beta regulates production of proteoglycans by mesangial cells . Kidney Int1990; 37: 689–695 .
62.
Ignotz RA , Massague J . Transforming growth factor-beta stimulates the expression of bironectin and collagen and their incorporation into the extracellular matrix . J Biol Chem1986; 261 (9): 4337–4345 .
63.
Grande J , Melder D , Zinsmeister A , Killen P . TGF-b1 induces collagen IV gene expression in NIH-3T3 cells . Lab Invest1993; 69: 387–395 .
64.
Grande JP , Melder DC , Zinsmeister AR . Modulation of collagen gene expression by cytokines: stimulatory effect of transforming growth factor-a on collagen type I and collagen type IV . J Lab Clin Med1997; 130: 476–486 .
65.
Okuda S , Languino LR , Ruoslahti E , Border WA . Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of mesangial extracellular matrix . J Clin Invest1990; 86: 453–462 .
66.
Coimbra T et al. Transforming growth factor-beta production in antiglomerular basement membrane disease in the rabbit . Am J Pathol1991; 138 (1): 223–234 .
67.
Kagami S , Border W , Ruoslahti E , Noble N . Coordinated expression of beta-1 integrins and TGF-beta1 induced matrix proteins in glomerulonephritis . Lab Invest1993; 69: 68–76 .
68.
Yamamoto T , Noble NA , Miller DE , Border WA . Sustained expression of TGF-b1 underlies development of progressive kidney fibrosis . Kidney Int1994; 45: 916–927 .
69.
Niemir ZI et al. PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis . Kidney Int1995; 48: 1530–1541 .
70.
Kaneto H , Morrissey J , Klahr S . Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation . Kidney Int1993; 44: 313–321 .
71.
Border WA et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta-1 . Nature1990; 346: 371–374 .
72.
Lowrance JH et al. Spontaneous elaboration of transforming growth factor b suppresses host defense against bacterial infection in autoimmune MRL/lpr mice . J Exp Med1994; 180: 1693–1703 .
73.
Nakamura T et al. Increased steady-state levels of mRNA coding for extracellular matrix components in kidneys of NZB/WF1 mice . Am J Pathol1991; 139: 437–450 .
74.
Nakamura T et al. Effect of methylprednisolone on transforming growth factor-beta, insulin-like growth factor-I, and basic fibroblast growth factor gene expression in the kidneys of NZB/WF1 mice . Renal Physiol Biochem1993; 16: 105–116 .
75.
Taniguchi Y et al. Role of transforming growth factor-b1in glomerulonephritis . J Int Med Res1997; 25: 71–80 .
76.
Harpel JG , Metz CN , Kojima S , Rifkin DB . Control of transforming growth factor-beta activity: latency vs. activation . Prog Growth Factor Res1992; 4: 321–335 .
77.
Munger JS et al. Latent transforming growth factor-beta: structural features and mechanisms of activation . Kidney Int1997; 51 (5): 1376–1382 .
78.
Lyons RM , Keski-Oja J , Moses HL . Proteolytic activation of latent transforming growth factor beta from fibroblast-conditioned medium . J Cell Biol1988; 106: 1659–1665 .
79.
Schultz-Cherry S , Ribeiro S , Gentry L , Murphy-Ullrich JE . Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system . J Biol Chem1994; 269: 26775–26782 .
80.
Lyons RM , Gentry LE , Purchio AF , Moses HL . Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin . J Cell Biol1990; 110: 1361–1367 .
81.
Barcellos-Hoff MH , Dix TA . Redox-mediated activation of latent transforming growth factor-b1 . Med Endocrinol1996; 10: 1077–1083 .
82.
Das SK , Fanbury BL . TGF-b1 produces a ‘pro-oxidant’ effect on bovine pulmonary artery endothelial cells in culture . Am J Physiol1991; 261 (5): L249–L254 .
83.
Ohba M , Shibanuma M , Kuroki T , Nose K . Production of hydrogen peroxide by transforming growth factor-beta1 and its involvement in induction of egr-1 in mouse osteoblastic cells . J Cell Biol1994; 126 (4): 1079–1088 .
84.
Kayanoki Y et al. Suppression of antioxidative enzyme expression by transforming growth factor beta-1 in rat hepatocytes , J Biol Chem1994; 269 (22): 15488–15492 .
85.
White AC , Das SK , Fanburg BL . Reduction in glutathione is associated with growth restriction and enlargement of bovine pulmonary artery endothelial cells produced by transforming growth factor-beta1 . Am J Respir Cell Mol Biol1992; 6: 364–368 .
86.
Das SK , White AC , Fanburg BL . Modulation of transforming growth factor-beta1 antiproliferative effects on endothelial cells by cysteine, cystine, and N-acetylcysteine . J Clin Invest1992; 90: 1649–1656 .
87.
Shibanuma M , Kuroki T , Nose K . Release of H2O2 and phosphorylation of 30 kilodalton proteins as early responses of cell cycledependent inhibition of DNA synthesis by transforming growth factor beta1 . Cell Growth Differ1991; 2: 583–591 .
